AgedNCT02774577
Oxygen Consumption After Acute Whole Body Vibration Session
A study testing whole body vibration training in vibrating platform in young and whole body vibration training in vibrating platform in elderly in people with Aged and Oxygen Consumption, run by Maíra F Pessoa at 1 site in Brazil.
Trial summary
Noninvasive assessment of VO2 during a single session of whole body vibration and changes in blood flow caused by the acute activity. Read more about this study
- Who is it for?
- Ages 20 to 74 yearsHealthy volunteers can take part
- Conditions the study is for
- Aged, Oxygen Consumption
- What is being tested?
- whole body vibration training in vibrating platform in young and whole body vibration training in vibrating platform in elderly
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 60 participants
- Where
- 1 siteBrazil
- Study dates
- 1 Jun 2016to 1 Jun 2017
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 20 to 74 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- healthy young adults (between 20 to 30 years) and healthy elderly (between 60 to 74 years), sedentary according International Physical Activity Questionnaire.
Who cannot join
- presence of thrombosis, labyrinthitis, osteoporosis and individuals who have difficulty adapting to the assessment or training protocol.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Acute Effects on Oxygen Consumption and Blood Flow After a Single Session of Whole Body Vibration
Noninvasive assessment of VO2 during a single session of whole body vibration and changes in blood flow caused by the acute activity.
Read the detailed description
A single whole body vibration session into two groups, a young adults groups and elderly group, booth healthy, will be held with concomitant collection of VO2 consumed during the session, by MetaMax cortex. Immediately after the session, it will be checked peripheral blood flow through US surface in color Doppler mode.
- Conditions
- Aged, Oxygen Consumption
- Being tested
- whole body vibration training in vibrating platform in young, whole body vibration training in vibrating platform in elderly
- Keywords
- Oxygen Consumption, Aged, Whole Body Vibration
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
whole body vibration training in vibrating platform in youngOther
Also called WBV
whole body vibration training in vibrating platform in elderlyOther
Also called WBV
| Study group | Role | What they receive |
|---|---|---|
| healthy young and elderly | Experimental | young adults (20 to 30 years) compare to elderly (60 to 74 years) Receives: Other: whole body vibration training in vibrating platform in young; Other: whole body vibration training in vibrating platform in elderly |
What is being measured
The primary outcome is the main question the study is designed to answer.
VO2 through the gas exchange measured by Cortex Metamax
an atoxic mask measure oxygen consumption and carbon dioxide production in ml/kg/min-1, breathe by breathe
Measured: up to 06 months
peripheral blood Lactate
a noninvasive evaluate using an Lactimeter
Measured: up to 06 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted17 May 2016 (estimated)
- Study start1 Jun 2016
- Primary completion1 Jun 2017
- Study completion1 Jun 2017
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for AgedStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Not applicable
- Intervention model
- Single group
- Model description
- acute wbv session, measuring ergospirometric variables during protocol and blood pressure, borg exertion, borg dyspnoea, blood lactate, heart rate and SpO2 before and after protocol.
- Masking
- None (open label)
- Enrolment
- 60 participants (actual)
Sponsor and investigators
- Lead sponsor
- Maíra F Pessoa
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor-investigator, Maíra F Pessoa, Universidade Federal de Pernambuco
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02774577
- Sponsor's protocol ID
- LACAP UFPernambuco
- Status last verified
- Oct 2017
- First submitted
- 11 May 2016
- Last updated
- 26 Oct 2017
- Results posted
- No
Study at a glance
From the registry record, last updated by the sponsor on 26 Oct 2017. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Acute Effects on Oxygen Consumption and Blood Flow After a Single Session of Whole Body Vibration
- ClinicalTrials.gov ID
- NCT02774577
- Acronym / sponsor ID
- LACAP UFPernambuco
- Conditions
- Aged, Oxygen Consumption
- Keywords
- Oxygen Consumption, Aged, Whole Body Vibration
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 60 participants (actual)
- Lead sponsor
- Maíra F PessoaUniversity, hospital or other
- Study start
- 1 Jun 2016 (actual)
- Primary completion
- 1 Jun 2017 (actual)
- Study completion
- 1 Jun 2017 (actual)
- First posted
- 17 May 2016 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Noninvasive assessment of VO2 during a single session of whole body vibration and changes in blood flow caused by the acute activity.
Detailed description
A single whole body vibration session into two groups, a young adults groups and elderly group, booth healthy, will be held with concomitant collection of VO2 consumed during the session, by MetaMax cortex. Immediately after the session, it will be checked peripheral blood flow through US surface in color Doppler mode.
Study design
- Primary purpose
- Health services research
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
- Model description
- acute wbv session, measuring ergospirometric variables during protocol and blood pressure, borg exertion, borg dyspnoea, blood lactate, heart rate and SpO2 before and after protocol.
| Arm | Type | Receives |
|---|---|---|
| healthy young and elderly | Experimental | Other: whole body vibration training in vibrating platform in young, Other: whole body vibration training in vibrating platform in elderlyyoung adults (20 to 30 years) compare to elderly (60 to 74 years) |
Who may qualify
- Ages
- 20 to 74 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- healthy young adults (between 20 to 30 years) and healthy elderly (between 60 to 74 years), sedentary according International Physical Activity Questionnaire.
Key exclusion criteria (1 listed)
- presence of thrombosis, labyrinthitis, osteoporosis and individuals who have difficulty adapting to the assessment or training protocol.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| whole body vibration training in vibrating platform in youngAlso: WBV | Other | healthy young and elderly |
| whole body vibration training in vibrating platform in elderlyAlso: WBV | Other | healthy young and elderly |
Primary outcome
VO2 through the gas exchange measured by Cortex Metamax
Time frame: up to 06 months
an atoxic mask measure oxygen consumption and carbon dioxide production in ml/kg/min-1, breathe by breathe
peripheral blood Lactate
Time frame: up to 06 months
a noninvasive evaluate using an Lactimeter
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 26 Oct 2017.
Related trials for Aged
RecruitingPhase 1
A Clinical Study of Letermovir (MK-8228) in Children and Adolescents Who Receive a Kidney Transplant (KT) (MK-8228-077)
Cytomegalovirus Prophylaxis
RecruitingPhase 1/2
Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms
Myelodysplastic Syndromes
RecruitingPhase 3
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
Clostridoides Difficile Associated Disease
Active, not recruitingPhase 4
A Study About the Safety of ASP3021 Eye Injections and if They Help People in Japan With Vision Loss From Age-related Macular Degeneration
Geographic Atrophy, Age-Related Macular Degeneration
Recruiting
Effects of Doll Therapy on Apathy and Activities of Daily Living Initiation Deficits in Older Adults With Dementia
Dementia
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing whole body vibration training in vibrating platform in young and whole body vibration training in vibrating platform in elderly in people with Aged and Oxygen Consumption, run by Maíra F Pessoa at 1 site in Brazil.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 26 Oct 2017. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Brazil. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
VO2 through the gas exchange measured by Cortex Metamax (time frame: up to 06 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Oct 2017.